BridgeBio Oncology Therapeutics

• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  bridgebiooncology.com

BridgeBio Oncology Therapeutics is a clinical-stage company focused on drug discovery and development targeting the RAS signaling pathway in cancer. The company aims to create novel RAS-targeted small molecules for patients with lethal cancers.